Five US based retailers sue Ranbaxy Labs, stock plunges

Drug maker Ranbaxy Labs fell 2.7% on Monday as The Financial Express reported that five US based retailers have sued the company and Pfizer for Lipitor generic delay.

July 09, 2012 / 12:45 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Drug maker Ranbaxy Labs fell 2.7% on Monday as The Financial Express reported that five US based retailers have sued the company and Pfizer for Lipitor generic delay.

The report says, "Five large US retailers - Walgreen Co, Kroger Co, Safeway Inc, SuperValu Inc and HEB Grocery Co - have filed an antitrust lawsuit against Ranbaxy Labs and pharma giant Pfizer in the US late last week, accusing them of conspiring to delay sales of generic versions of Lipitor, the biggest blockbuster drug in the history of pharmaceuticals. This is the second lawsuit of this nature in last eight months defending in the US over Lipitor."

At 12:08 hours IST, the share was trading at Rs 491.85, down Rs 13.20, or 2.61% with volumes of 40,710 shares.

first published: Jul 9, 2012 12:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347